2012-09-18 08:02:59 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's pharmaceuticals report, "Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2012" provides data on the Inotek Pharmaceuticals Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Inotek Pharmaceuticals Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Inotek Pharmaceuticals Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Inotek Pharmaceuticals Corporation - Brief Inotek Pharmaceuticals Corporation overview including business description, key information and facts, and its locations and subsidiaries.
*

Review of current pipeline of Inotek Pharmaceuticals Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Inotek Pharmaceuticals Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Inotek Pharmaceuticals Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463682_inotek_pharmaceuticals_corporation_pr ..


Reasons to buy

* Evaluate Inotek Pharmaceuticals Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Inotek Pharmaceuticals Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Inotek Pharmaceuticals Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Inotek Pharmaceuticals Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Inotek Pharmaceuticals Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Inotek Pharmaceuticals Corporation; Inotek Pharmaceuticals Corporation - Key Therapeutics; Inotek Pharmaceuticals Corporation - Pipeline Overview and Promising Molecules; Inotek Pharmaceuticals Corporation - News; Inotek Pharmaceuticals Corporation - Latest Updates; Inotek Pharmaceuticals Corporation - Pipeline; Inotek Pharmaceuticals Corporation - Discontinued/Dormant Projects

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Inotek Pharmaceuticals Corporation Snapshot
Inotek Pharmaceuticals Corporation Overview
Key Information
Key Facts
Inotek Pharmaceuticals Corporation - Research and Development Overview
Key Therapeutic Areas
Inotek Pharmaceuticals Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Inotek Pharmaceuticals Corporation - Pipeline Products Glance
Inotek Pharmaceuticals Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Inotek Pharmaceuticals Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Inotek Pharmaceuticals Corporation - Drug Profiles
INO-6002
Product Description
Mechanism of Action
R&D Progress
INO-741
Product Description
Mechanism of Action
R&D Progress
INO-763
Product Description
Mechanism of Action
R&D Progress
INO-8875
Product Description
Mechanism of Action
R&D Progress
PARP Inhibitors
Product Description
Mechanism of Action
R&D Progress
SOD Mimetic
Product Description
Mechanism of Action
R&D Progress
Inotek Pharmaceuticals Corporation - Pipeline Analysis
Inotek Pharmaceuticals Corporation - Pipeline Products by Therapeutic Class
Inotek Pharmaceuticals Corporation - Pipeline Products by Route of Administration
Inotek Pharmaceuticals Corporation - Pipeline Products By Mechanism of Action
Inotek Pharmaceuticals Corporation - Recent Pipeline Updates
Inotek Pharmaceuticals Corporation - Dormant Projects
Inotek Pharmaceuticals Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
PJ34
Inotek Pharmaceuticals Corporation - Locations And Subsidiaries
Head Office
Inotek Pharmaceuticals Corporation, Recent Developments
Inotek Pharmaceuticals Corporation- Press Release
Jun 25, 2009: Inotek Pharmaceuticals' Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure In Phase 1/2 Study
May 06, 2009: Inotek Pharmaceuticals Presents Preclinical Data In Support Of Novel Glaucoma Candidate, INO-8875 At ARVO

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463682&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.